Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Corvus Pharmaceuticals Inc sell StockNews.com

Start price
€0.68
18.03.23 / 50%
Target price
-
18.03.24
Performance (%)
157.58%
End price
€1.75
19.03.24
Summary
This prediction ended on 19.03.24 with a price of €1.75. The SELL prediction by StockNews_com for Corvus Pharmaceuticals Inc was trending in the completely wrong direction and closed with a performance of 157.58%. StockNews_com has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Corvus Pharmaceuticals Inc 14.909% 14.909% -1.250%
iShares Core DAX® 1.851% 5.158% 17.711%
iShares Nasdaq 100 1.573% 2.589% 39.053%
iShares Nikkei 225® -0.412% -2.857% 13.501%
iShares S&P 500 1.128% 2.485% 29.871%

Comments by StockNews_com for this prediction

In the thread Corvus Pharmaceuticals Inc diskutieren

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CRVS provided by MarketBeat

In the thread Trading Corvus Pharmaceuticals Inc
Prediction Sell
Perf. (%) 157.58%
Target price
Change
Ends at 18.03.24

Die von StockNews_com gewählte maximale Laufzeit wurde überschritten

Stopped prediction by StockNews_com for Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€0.92
03.04.23
-
03.04.24
81.96%
04.04.24

Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€0.65
26.03.23
-
26.03.24
144.58%
27.03.24